Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)

176 filings reported holding TVTX - Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 60,583,594 shares of 89,414,894 outstanding shares and own 67.76% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (5,748,000 shares), RA CAPITAL MANAGEMENT, L.P. (5,614,428 shares), BlackRock Inc. (4,992,525 shares), MACQUARIE GROUP LTD (3,912,413 shares), JANUS HENDERSON GROUP PLC (3,905,113 shares), VANGUARD GROUP INC (3,834,756 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3,593,763 shares), STATE STREET CORP (3,453,859 shares), GOLDMAN SACHS GROUP INC (2,457,280 shares), and PERCEPTIVE ADVISORS LLC (1,845,555 shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.